Annals of Surgical Oncology

, Volume 10, Issue 7, pp 740–747 | Cite as

Small Invasive Breast Carcinomas in Taiwanese Women

  • Tzu-Chieh Chao
  • Miin-Fu Chen
  • Chia-Siu Wang
  • Yi-Yin Jan
  • Tsann-Long Hwang
  • Shin-Cheh Chen
Original Articles


Background: Female Taiwanese breast cancer patients are younger than their Western counterparts. This study examined the predictors of axillary lymph node metastases in Taiwanese women with T1 breast cancer.

Methods: Data from 394 Taiwanese women with T1 invasive breast carcinoma were retrospectively reviewed.

Results: The data contained 6 T1a, 51 T1b, and 337 T1c breast tumors. The patients’ ages ranged from 23 to 82 years (mean ± SD, 48.2 ± 11.4 years; median, 46.4 years). Axillary nodal metastases were present in 38.3% of the patients (16.7% in T1a, 35.3% in T1b, and 39.2% in T1c tumors). The patients with nodal metastases had significantly greater body weights and S-phase fractions than those without nodal metastases. Univariate analysis revealed that unfavorable pathology, lymphovascular invasion, S-phase fraction >7%, and nondiploid DNA ploidy were significantly associated with lymph node metastases. Lymphovascular invasion was the only significant variable as the independent predictor in the multiple logistic regression analysis. In the Cox proportional hazards regression analysis, axillary nodal status and lymphovascular invasion were significantly associated with survival.

Conclusions: Taiwanese women with small breast cancer displayed a relatively higher incidence of axillary lymph node metastases than Western women. Axillary lymph node dissection or sentinel lymph node biopsy should be conducted on Taiwanese patients with small invasive breast carcinomas, particularly when risk factors exist.

Key Words:

Breast cancer DNA ploidy Lymphovascular invasion Lymph nodes S-phase fraction Survival 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989; 63: 181–7.PubMedCrossRefGoogle Scholar
  2. 2.
    Cady B, Stone MD, Schuler JG, Thakur R, Wanner MA, Lavin PT. The new era in breast cancer. Arch Surg 1996; 131: 301–8.PubMedGoogle Scholar
  3. 3.
    Harris JR, Lippman ME, Veronesi U, Willet W. Breast cancer. N Engl J Med 1992; 327: 473–80.PubMedCrossRefGoogle Scholar
  4. 4.
    Mansour EG, Ravdin PM, Dressler L. Prognostic factors in early breast carcinoma. Cancer 1994; 7: 381–400.CrossRefGoogle Scholar
  5. 5.
    Wold LE, Ingle JN, Pisansky TM, Johnson RE, Donohue JH. Prognostic factors for patients with carcinoma of the breast. Mayo Clin Proc 1995; 70: 678–79.PubMedGoogle Scholar
  6. 6.
    Mustafa IA, Cole B, Wanebo HJ, Bland KI, Chang HR. The impact of histopathology on nodal metastases in minimal breast cancer. Arch Surg 1997; 132: 384–91.PubMedGoogle Scholar
  7. 7.
    Barth A, Craig PH, Silverstein MJ. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma. Cancer 1997; 79: 1918–22.PubMedCrossRefGoogle Scholar
  8. 8.
    Abner AL, Collins L, Peiro G, et al. Correlation of tumor size and axillary lymph node involvement with prognosis in patients with T1 breast carcinoma. Cancer 1998; 83: 2502–8.PubMedCrossRefGoogle Scholar
  9. 9.
    Chadha M, Chabon AB, Friedmann P, Vikram B. Predictors of axillary lymph node metastases in patients with T1 breast cancer. A multivariate analysis. Cancer 1994; 73: 350–3.PubMedCrossRefGoogle Scholar
  10. 10.
    Shoup M, Malinzak L, Weisenberger J, Aranha GV. Predictors of axillary lymph node metastases in T1 breast carcinoma. Am Surg 1999; 65: 748–53.PubMedGoogle Scholar
  11. 11.
    Silverstein MJ, Gierson ED, Waisman JR, Senofsky GM, Colburn WJ, Gamagami P. Axillary lymph node dissection for T1a breast carcinoma. Is it indicated? Cancer 1994; 73: 664–7.PubMedCrossRefGoogle Scholar
  12. 12.
    Lin PP, Allison DC, Wainstock J, et al. Impact of axillary lymph node dissection on the therapy of breast cancer patients. J Clin Oncol 1993; 11: 1536–44.PubMedGoogle Scholar
  13. 13.
    Maibenco DC, Weiss LK, Pawlish KS, Severson RK. Axillary lymph node metastases associated with small invasive breast carcinomas. Cancer 1999; 85: 1530–6.PubMedCrossRefGoogle Scholar
  14. 14.
    Saiz E, Toonkel R, Poppiti RJ, Robinson MJ. Infiltrating breast carcinoma smaller than 0.5 centimeters. Is lymph node dissection necessary? Cancer 1999; 85: 2206–11.PubMedCrossRefGoogle Scholar
  15. 15.
    Port ER, Tan LK, Borgen PI, Van Zee KJ. Incidence of axillary lymph node metastases in T1a and T1b breast carcinoma. Ann Surg Oncol 1998; 5: 23–7.PubMedCrossRefGoogle Scholar
  16. 16.
    McGee JM, Youmans R, Clingan F, Malnar K, Bellefeuille C, Berry B. The value of axillary dissection in T1a breast cancer. Am J Surg 1996; 172: 501–4.PubMedCrossRefGoogle Scholar
  17. 17.
    White RE, Vezeridis MP, Konstadoulakis A, Cole BF, Wanebo HJ. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions. J Am Coll Surg 1996; 183: 575–82.PubMedGoogle Scholar
  18. 18.
    Sosa JA, Diener-West M, Gusev Y, et al. Association between extent of axillary lymph node dissection and survival in patients with stage I breast cancer. Ann Surg Oncol 1998; 5: 140–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Bland KI, Coburn MC. Wound care and complications of mastectomy. In: Bland KI, Copeland EM, eds. The Breast: Comprehensive Management of Benign and Malignant Diseases. Philadelphia: WB Saunders Co, 1998: 995–1002.Google Scholar
  20. 20.
    Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer: a multicenter validation study. N Engl J Med 1998; 339: 941–6.PubMedCrossRefGoogle Scholar
  21. 21.
    Dowlatshahi K, Fan M, Anderson JM, Bloom KJ. Occult metastases in sentinel nodes of 200 patients with operable breast cancer. Ann Surg Oncol 2001; 8: 675–82.PubMedCrossRefGoogle Scholar
  22. 22.
    Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993; 54: 594–606.PubMedCrossRefGoogle Scholar
  23. 23.
    Cheng SH, Tsou M-F, Liu M-C, et al. Unique features of breast cancer in Taiwan. Breast Cancer Res Treat 2000; 63: 213–23.PubMedCrossRefGoogle Scholar
  24. 24.
    Natarajan N, Nemoto D, Nemoto T, Mettlin C. Breast cancer survival among Orientals and whites living in the United States. J Surg Oncol 1988; 39: 206–9.PubMedCrossRefGoogle Scholar
  25. 25.
    Hsu JL, Glaser SL, West DW. Racial/ethnic differences in breast cancer survival among San Francisco Bay Area women. J Natl Cancer Inst 2001; 89: 1311–2.CrossRefGoogle Scholar
  26. 26.
    Hannequin P, Liehn JC, Delisle MJ. Multifactorial analysis of survival in thyroid cancer: pitfalls of applying the results of published studies to another population. Cancer 1986; 58: 1749–55.PubMedCrossRefGoogle Scholar
  27. 27.
    Bosl GJ, Geller NL, Cirrincione C, et al. Multivariate analysis of prognostic variables in patients with metastatic testicular cancer. Cancer Res 1983; 43: 3403–7.PubMedGoogle Scholar
  28. 28.
    Breast cancer staging. In: Fleming ID, Cooper JS, Henson DE, et al., eds. AJCC Cancer Staging Manual. Philadelphia: Lippincott-Raven, 1997: 171–80.Google Scholar
  29. 29.
    Fisher B, Wolmark N, Bauer M, Redmond C, Gebhardt M. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet 1981; 152: 765–72.PubMedGoogle Scholar
  30. 30.
    Kiricuta CI, Tausch J, Math D. A mathematical model of axillary lymph node involvement based on 1446 complete axillary dissections in patients with breast carcinoma. Cancer 1992; 69: 2496–501.PubMedCrossRefGoogle Scholar
  31. 31.
    Axelsson CK, Mouridsen HT, Zedeler K. Axillary dissection of level I and II lymph nodes is important in breast cancer classification. Eur J Cancer 1992; 28A: 1415–8.PubMedCrossRefGoogle Scholar
  32. 32.
    Rivadeneira DE, Simmons RM, Christos PJ, Hanna K, Daly JM, Osborne MP. Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients. J Am Coll Surg 2000; 191: 1–6.PubMedCrossRefGoogle Scholar
  33. 33.
    Kallioniemi OP, Blanco G, Alavaikko M, et al. Improving the prognostic value of DNS flow cytometry in breast cancer by combining DNA index and S-phase fraction. A proposed classification of DNA histograms in breast cancer. Cancer 1988; 62: 2183–90.PubMedCrossRefGoogle Scholar
  34. 34.
    Meyer JS. Cell kinetics of breast and breast tumors. In: Donegan WL, Spratt JS, eds. Cancer of the Breast. Philadelphia: WB Saunders Co, 1995: 279–308.Google Scholar
  35. 35.
    Wenger CR, Beardslee S, Owens MA, et al. DNA ploidy, S-phase, and steroid receptors in more than 127,000 breast cancer patients. Breast Cancer Res Treat 1993; 28: 9–20.PubMedCrossRefGoogle Scholar
  36. 36.
    Ravdin PM, De Laurentiis M, Vendely T, Clark GM. Prediction of axillary lymph node status in breast cancer patients by use of prognostic indicators. J Natl Cancer Inst 1994; 86: 1771–5.PubMedCrossRefGoogle Scholar
  37. 37.
    Olivotto IA, Jackson JS, Mates D, et al. Prediction of axillary lymph node involvement of women with invasive breast carcinoma. Cancer 1998; 83: 948–55.PubMedCrossRefGoogle Scholar
  38. 38.
    Chontos AJ, Maher DP, Ratzer ER, Fenoglio ME. Axillary lymph node dissection: is it required in T1a breast cancer? J Am Coll Surg 1997; 184: 493–8.PubMedGoogle Scholar
  39. 39.
    Seidman JD, Schnaper LA, Aisner SC. Relationship of the size of the invasive component of the primary breast carcinoma to axillary lymph node metastases. Cancer 1995; 75: 65–71.PubMedCrossRefGoogle Scholar
  40. 40.
    Yang WT, Lam WW, Cheung H, Suen M, King WW, Metreweli C. Sonographic, magnetic resonance imaging, and mammographic assessments of preoperative size of breast cancer. J Ultrasound Med 1997; 16: 791–7.PubMedGoogle Scholar
  41. 41.
    Tresserra F, Feu J, Grases PJ, Navarro B, Alegret X, Fernandez-Cid A. Assessment of breast cancer size: sonographic and pathologic correlation. J Clin Ultrasound 1999; 27: 485–91.PubMedCrossRefGoogle Scholar
  42. 42.
    Finlayson CA, MacDermott TA. Ultrasound can estimate the pathologic size of infiltrating ductal carcinoma. Arch Surg 2000; 135: 158–9.PubMedCrossRefGoogle Scholar
  43. 43.
    Lin SS, Clarke CA, Prehn AW, Glaser SL, West DW, O’Malley CD. Survival differences among Asian subpopulations in the United States after prostate, colorectal, breast, and cervical carcinomas. Cancer 2002; 94: 1175–82.PubMedCrossRefGoogle Scholar
  44. 44.
    Li CI, Malone KE, Daling JR. Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med 2003; 163: 49–56.PubMedCrossRefGoogle Scholar
  45. 45.
    Ziegler RG, Hoover RN, Pike MC, et al. Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 1993; 85: 1819–27.PubMedCrossRefGoogle Scholar
  46. 46.
    Deapen D, Liu L, Perkins C, Bernstein L, Ross RK. Rapidly rising breast cancer incidence rates among Asian-American women. Int J Cancer 2002; 99: 747–50.PubMedCrossRefGoogle Scholar
  47. 47.
    Chao T-C, Lo Y-F, Chen S-C, Chen M-F. Prospective sonographic study of 3093 breast tumors. J Ultrasound Med 1999; 18: 363–70.PubMedGoogle Scholar
  48. 48.
    Rosen PP, Lesser ML, Kinne DW, Beattie EJ. Breast carcinoma in women 35 years or younger. Ann Surg 1985; 119: 133–42.Google Scholar
  49. 49.
    Diab SG, Elledge RM, Clark GM. Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst 2000; 92: 550–6.PubMedCrossRefGoogle Scholar
  50. 50.
    Lyman GH, Lyman S, Balducci L, et al. Age and the risk of breast cancer recurrence. Cancer Control 1996; 3: 421–7.PubMedGoogle Scholar
  51. 51.
    Mann GB, Port ER, Rizza C, Tan LK, Borgen PI, Van Zee KJ. Six-year follow-up of patients with microinvasive, T1a, and T1b breast carcinoma. Ann Surg Oncol 1999; 6: 591–8.PubMedCrossRefGoogle Scholar
  52. 52.
    Mustafa IA, Cole B, Wanebo HJ, Bland KI, Chang HR. Prognostic analysis of survival in small breast cancers. J Am Coll Surg 1998; 186: 562–9.PubMedCrossRefGoogle Scholar
  53. 53.
    Velanovich V. Axillary lymph node dissection for breast cancer: a decision analysis of T1 lesions. Ann Surg Oncol 1998; 5: 131–9.PubMedCrossRefGoogle Scholar
  54. 54.
    Pandelidis SM, Peters K, Walusimbi MS, et al. The role of axillary dissection in mammographically detected carcinoma. J Am Coll Surg 1997; 184: 341–5.PubMedGoogle Scholar
  55. 55.
    Ruffin WK, Stacey-Clear A, Younger J, Hoover HC Jr. Rationale for routine axillary dissection in carcinoma of the breast. J Am Coll Surg 1995; 180: 245–51.PubMedGoogle Scholar
  56. 56.
    Giuliano A, Barth A, Spivack B, Beitsch PD, Evans SW. Incidence and predictors of axillary metastases in T1 carcinoma of the breast. J Am Coll Surg 1996; 183: 185–9.PubMedGoogle Scholar
  57. 57.
    Shetty M, Reiman H Jr. Tumor size and axillary metastasis. A correlative occurrence in 1244 cases of breast cancer between 1980 and 1995. Eur J Surg Oncol 1997; 23: 139–41.PubMedCrossRefGoogle Scholar
  58. 58.
    Port RE, Tan LK, Borgen PI, Van Zee KJ. Incidence of axillary lymph node metastases in T1a and T1b breast carcinoma. Ann Surg Oncol 1998; 5: 23–7.PubMedCrossRefGoogle Scholar

Copyright information

© The Society of Surgical Oncology, Inc. 2003

Authors and Affiliations

  • Tzu-Chieh Chao
    • 1
    • 2
  • Miin-Fu Chen
    • 1
  • Chia-Siu Wang
    • 1
  • Yi-Yin Jan
    • 1
  • Tsann-Long Hwang
    • 1
  • Shin-Cheh Chen
    • 1
  1. 1.Division of General Surgery, Department of SurgeryChang Gung University College of Medicine; and Chang Gung Memorial HospitalTaoyuanTaiwan
  2. 2.Department of SurgeryChang Gung Memorial HospitalKeelungTaiwan

Personalised recommendations